After calculating the total CPBS score for each patient, they were categorized into three prognostic groups: in the ER+HER2– BC group, a low-risk group had a score of 0, an intermediate-risk group had a score of 1, and a high-risk group had a score of 2–4. Here, ERBB2 is linked to breast cancer.